nodes	percent_of_prediction	percent_of_DWPC	metapath
Lapatinib—CYP2C8—Bupropion—obesity	0.0706	0.158	CbGbCtD
Lapatinib—CYP3A5—Cimetidine—obesity	0.0539	0.12	CbGbCtD
Lapatinib—CYP2C8—Cimetidine—obesity	0.0518	0.116	CbGbCtD
Lapatinib—CYP3A4—Sibutramine—obesity	0.0444	0.0991	CbGbCtD
Lapatinib—CYP2C19—Cimetidine—obesity	0.0435	0.097	CbGbCtD
Lapatinib—ABCB1—Cimetidine—obesity	0.0351	0.0783	CbGbCtD
Lapatinib—CYP3A4—Benzphetamine—obesity	0.0337	0.0751	CbGbCtD
Lapatinib—CYP3A4—Bupropion—obesity	0.0286	0.0639	CbGbCtD
Lapatinib—CYP2C19—Topiramate—obesity	0.0285	0.0635	CbGbCtD
Lapatinib—CYP3A4—Orlistat—obesity	0.0233	0.0521	CbGbCtD
Lapatinib—CYP3A4—Cimetidine—obesity	0.021	0.0469	CbGbCtD
Lapatinib—CYP3A4—Topiramate—obesity	0.0138	0.0307	CbGbCtD
Lapatinib—ERBB2—gall bladder—obesity	0.00567	0.0521	CbGeAlD
Lapatinib—TAP1—islet of Langerhans—obesity	0.00509	0.0468	CbGeAlD
Lapatinib—TAP1—adrenal cortex—obesity	0.00403	0.0371	CbGeAlD
Lapatinib—PIK3C2B—adrenal cortex—obesity	0.00379	0.0348	CbGeAlD
Lapatinib—ERBB2—respiratory system—obesity	0.00351	0.0322	CbGeAlD
Lapatinib—ERBB4—respiratory system—obesity	0.00351	0.0322	CbGeAlD
Lapatinib—PI4KB—islet of Langerhans—obesity	0.00348	0.032	CbGeAlD
Lapatinib—PI4KB—respiratory system—obesity	0.00329	0.0302	CbGeAlD
Lapatinib—TAP1—pituitary gland—obesity	0.00326	0.0299	CbGeAlD
Lapatinib—TAP1—adipose tissue—obesity	0.00324	0.0298	CbGeAlD
Lapatinib—PIK3C2B—pituitary gland—obesity	0.00306	0.0281	CbGeAlD
Lapatinib—PIK3C2B—adipose tissue—obesity	0.00305	0.028	CbGeAlD
Lapatinib—TAP1—adrenal gland—obesity	0.00291	0.0268	CbGeAlD
Lapatinib—PI4KB—adrenal cortex—obesity	0.00276	0.0253	CbGeAlD
Lapatinib—PIK3C2B—adrenal gland—obesity	0.00273	0.0251	CbGeAlD
Lapatinib—ERBB2—cardiovascular system—obesity	0.00269	0.0247	CbGeAlD
Lapatinib—ERBB4—cardiovascular system—obesity	0.00269	0.0247	CbGeAlD
Lapatinib—ERBB4—pituitary gland—obesity	0.00238	0.0219	CbGeAlD
Lapatinib—PIK3C2B—endocrine gland—obesity	0.00237	0.0218	CbGeAlD
Lapatinib—ERBB2—adipose tissue—obesity	0.00237	0.0218	CbGeAlD
Lapatinib—ERBB4—adipose tissue—obesity	0.00237	0.0218	CbGeAlD
Lapatinib—TAP1—liver—obesity	0.00228	0.0209	CbGeAlD
Lapatinib—ERBB2—digestive system—obesity	0.00223	0.0205	CbGeAlD
Lapatinib—PI4KB—pituitary gland—obesity	0.00223	0.0205	CbGeAlD
Lapatinib—PI4KB—adipose tissue—obesity	0.00222	0.0204	CbGeAlD
Lapatinib—PIK3C2B—liver—obesity	0.00214	0.0196	CbGeAlD
Lapatinib—ERBB2—adrenal gland—obesity	0.00213	0.0195	CbGeAlD
Lapatinib—EGFR—adipose tissue—obesity	0.00201	0.0185	CbGeAlD
Lapatinib—PI4KB—adrenal gland—obesity	0.00199	0.0183	CbGeAlD
Lapatinib—ERBB2—endocrine gland—obesity	0.00184	0.0169	CbGeAlD
Lapatinib—ERBB4—endocrine gland—obesity	0.00184	0.0169	CbGeAlD
Lapatinib—EGFR—adrenal gland—obesity	0.0018	0.0166	CbGeAlD
Lapatinib—PI4KB—endocrine gland—obesity	0.00173	0.0159	CbGeAlD
Lapatinib—ERBB2—liver—obesity	0.00166	0.0153	CbGeAlD
Lapatinib—PI4KB—liver—obesity	0.00156	0.0143	CbGeAlD
Lapatinib—EGFR—liver—obesity	0.00141	0.0129	CbGeAlD
Lapatinib—Gastrointestinal disorder—Benzphetamine—obesity	0.00126	0.00719	CcSEcCtD
Lapatinib—Insomnia—Phendimetrazine—obesity	0.00121	0.00687	CcSEcCtD
Lapatinib—Palpitations—Phentermine—obesity	0.00118	0.00672	CcSEcCtD
Lapatinib—Alopecia—Diethylpropion—obesity	0.00118	0.00672	CcSEcCtD
Lapatinib—Decreased appetite—Phendimetrazine—obesity	0.00116	0.0066	CcSEcCtD
Lapatinib—Nail disorder—Topiramate—obesity	0.00116	0.00659	CcSEcCtD
Lapatinib—Constipation—Phendimetrazine—obesity	0.00114	0.00649	CcSEcCtD
Lapatinib—Alopecia—Cimetidine—obesity	0.00112	0.00639	CcSEcCtD
Lapatinib—Hypersensitivity—Methamphetamine—obesity	0.00112	0.00636	CcSEcCtD
Lapatinib—Hypersensitivity—Benzphetamine—obesity	0.00108	0.00614	CcSEcCtD
Lapatinib—Menopausal symptoms—Orlistat—obesity	0.00108	0.00612	CcSEcCtD
Lapatinib—Abdominal pain—Phendimetrazine—obesity	0.00106	0.006	CcSEcCtD
Lapatinib—Leukopenia—Diethylpropion—obesity	0.00104	0.00592	CcSEcCtD
Lapatinib—Diarrhoea—Methamphetamine—obesity	0.00104	0.00591	CcSEcCtD
Lapatinib—Insomnia—Phenylpropanolamine—obesity	0.00103	0.00587	CcSEcCtD
Lapatinib—Palpitations—Diethylpropion—obesity	0.00103	0.00585	CcSEcCtD
Lapatinib—Dyspnoea—Phenylpropanolamine—obesity	0.00102	0.00578	CcSEcCtD
Lapatinib—Diarrhoea—Benzphetamine—obesity	0.001	0.0057	CcSEcCtD
Lapatinib—Leukopenia—Cimetidine—obesity	0.000991	0.00563	CcSEcCtD
Lapatinib—Myalgia—Diethylpropion—obesity	0.00099	0.00563	CcSEcCtD
Lapatinib—Insomnia—Phentermine—obesity	0.000987	0.00561	CcSEcCtD
Lapatinib—Pain in extremity—Sibutramine—obesity	0.000982	0.00558	CcSEcCtD
Lapatinib—Constipation—Phenylpropanolamine—obesity	0.000975	0.00555	CcSEcCtD
Lapatinib—Dyspepsia—Phentermine—obesity	0.000961	0.00546	CcSEcCtD
Lapatinib—Headache—Methamphetamine—obesity	0.000952	0.00541	CcSEcCtD
Lapatinib—Arthralgia—Cimetidine—obesity	0.000942	0.00536	CcSEcCtD
Lapatinib—Myalgia—Cimetidine—obesity	0.000942	0.00536	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Phentermine—obesity	0.000942	0.00536	CcSEcCtD
Lapatinib—Fatigue—Phentermine—obesity	0.000941	0.00535	CcSEcCtD
Lapatinib—Constipation—Phentermine—obesity	0.000933	0.00531	CcSEcCtD
Lapatinib—Dry skin—Orlistat—obesity	0.00093	0.00529	CcSEcCtD
Lapatinib—Headache—Benzphetamine—obesity	0.000918	0.00522	CcSEcCtD
Lapatinib—Hot flush—Bupropion—obesity	0.000915	0.0052	CcSEcCtD
Lapatinib—Diarrhoea—Phendimetrazine—obesity	0.000913	0.00519	CcSEcCtD
Lapatinib—Dehydration—Sibutramine—obesity	0.000913	0.00519	CcSEcCtD
Lapatinib—CYP3A5—islet of Langerhans—obesity	0.000911	0.00837	CbGeAlD
Lapatinib—Menopausal symptoms—Bupropion—obesity	0.000907	0.00516	CcSEcCtD
Lapatinib—Anaphylactic shock—Cimetidine—obesity	0.000903	0.00514	CcSEcCtD
Lapatinib—Dry skin—Sibutramine—obesity	0.0009	0.00512	CcSEcCtD
Lapatinib—Nausea—Benzphetamine—obesity	0.00087	0.00495	CcSEcCtD
Lapatinib—Alanine aminotransferase increased—Sibutramine—obesity	0.000866	0.00493	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Diethylpropion—obesity	0.000865	0.00492	CcSEcCtD
Lapatinib—Abdominal pain—Phentermine—obesity	0.000863	0.00491	CcSEcCtD
Lapatinib—CYP3A5—respiratory system—obesity	0.00086	0.00791	CbGeAlD
Lapatinib—Insomnia—Diethylpropion—obesity	0.000859	0.00488	CcSEcCtD
Lapatinib—Pain in extremity—Bupropion—obesity	0.000856	0.00487	CcSEcCtD
Lapatinib—Dyspnoea—Diethylpropion—obesity	0.000846	0.00481	CcSEcCtD
Lapatinib—Hypersensitivity—Phenylpropanolamine—obesity	0.00084	0.00478	CcSEcCtD
Lapatinib—Headache—Phendimetrazine—obesity	0.000836	0.00476	CcSEcCtD
Lapatinib—Dyspepsia—Diethylpropion—obesity	0.000836	0.00475	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Cimetidine—obesity	0.000823	0.00468	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Diethylpropion—obesity	0.00082	0.00466	CcSEcCtD
Lapatinib—Constipation—Diethylpropion—obesity	0.000812	0.00462	CcSEcCtD
Lapatinib—Dehydration—Bupropion—obesity	0.000796	0.00453	CcSEcCtD
Lapatinib—Nausea—Phendimetrazine—obesity	0.000793	0.00451	CcSEcCtD
Lapatinib—Dry skin—Bupropion—obesity	0.000785	0.00446	CcSEcCtD
Lapatinib—Asthenia—Phentermine—obesity	0.000783	0.00445	CcSEcCtD
Lapatinib—Infestation NOS—Orlistat—obesity	0.000782	0.00445	CcSEcCtD
Lapatinib—Infestation—Orlistat—obesity	0.000782	0.00445	CcSEcCtD
Lapatinib—Fatigue—Cimetidine—obesity	0.000779	0.00443	CcSEcCtD
Lapatinib—Constipation—Cimetidine—obesity	0.000772	0.00439	CcSEcCtD
Lapatinib—Neuropathy peripheral—Orlistat—obesity	0.000766	0.00436	CcSEcCtD
Lapatinib—Pneumonia—Sibutramine—obesity	0.000761	0.00433	CcSEcCtD
Lapatinib—Diarrhoea—Phentermine—obesity	0.000747	0.00425	CcSEcCtD
Lapatinib—Neuropathy peripheral—Sibutramine—obesity	0.000742	0.00422	CcSEcCtD
Lapatinib—Hepatobiliary disease—Orlistat—obesity	0.000739	0.00421	CcSEcCtD
Lapatinib—Stomatitis—Sibutramine—obesity	0.000738	0.00419	CcSEcCtD
Lapatinib—Vomiting—Phenylpropanolamine—obesity	0.000725	0.00412	CcSEcCtD
Lapatinib—Rash—Phenylpropanolamine—obesity	0.000719	0.00409	CcSEcCtD
Lapatinib—Dermatitis—Phenylpropanolamine—obesity	0.000718	0.00409	CcSEcCtD
Lapatinib—Epistaxis—Sibutramine—obesity	0.000714	0.00406	CcSEcCtD
Lapatinib—CYP2C19—digestive system—obesity	0.000694	0.00638	CbGeAlD
Lapatinib—Vomiting—Phentermine—obesity	0.000694	0.00395	CcSEcCtD
Lapatinib—Rash—Phentermine—obesity	0.000688	0.00391	CcSEcCtD
Lapatinib—Dermatitis—Phentermine—obesity	0.000687	0.00391	CcSEcCtD
Lapatinib—Headache—Phentermine—obesity	0.000684	0.00389	CcSEcCtD
Lapatinib—Nausea—Phenylpropanolamine—obesity	0.000677	0.00385	CcSEcCtD
Lapatinib—Hypersensitivity—Cimetidine—obesity	0.000665	0.00378	CcSEcCtD
Lapatinib—Pneumonia—Bupropion—obesity	0.000664	0.00377	CcSEcCtD
Lapatinib—Infestation—Bupropion—obesity	0.00066	0.00375	CcSEcCtD
Lapatinib—Infestation NOS—Bupropion—obesity	0.00066	0.00375	CcSEcCtD
Lapatinib—Diarrhoea—Diethylpropion—obesity	0.00065	0.00369	CcSEcCtD
Lapatinib—Nausea—Phentermine—obesity	0.000648	0.00369	CcSEcCtD
Lapatinib—Asthenia—Cimetidine—obesity	0.000648	0.00369	CcSEcCtD
Lapatinib—Neuropathy peripheral—Bupropion—obesity	0.000647	0.00368	CcSEcCtD
Lapatinib—CYP2C8—pituitary gland—obesity	0.000646	0.00594	CbGeAlD
Lapatinib—Stomatitis—Bupropion—obesity	0.000643	0.00366	CcSEcCtD
Lapatinib—Immune system disorder—Orlistat—obesity	0.000634	0.00361	CcSEcCtD
Lapatinib—Mediastinal disorder—Orlistat—obesity	0.000633	0.0036	CcSEcCtD
Lapatinib—Epistaxis—Bupropion—obesity	0.000622	0.00354	CcSEcCtD
Lapatinib—Alopecia—Orlistat—obesity	0.00062	0.00353	CcSEcCtD
Lapatinib—Diarrhoea—Cimetidine—obesity	0.000618	0.00351	CcSEcCtD
Lapatinib—Angiopathy—Sibutramine—obesity	0.000616	0.00351	CcSEcCtD
Lapatinib—Mental disorder—Orlistat—obesity	0.000615	0.0035	CcSEcCtD
Lapatinib—Immune system disorder—Sibutramine—obesity	0.000614	0.00349	CcSEcCtD
Lapatinib—Malnutrition—Orlistat—obesity	0.000611	0.00347	CcSEcCtD
Lapatinib—Vomiting—Diethylpropion—obesity	0.000604	0.00343	CcSEcCtD
Lapatinib—Alopecia—Sibutramine—obesity	0.0006	0.00341	CcSEcCtD
Lapatinib—Rash—Diethylpropion—obesity	0.000599	0.0034	CcSEcCtD
Lapatinib—Dermatitis—Diethylpropion—obesity	0.000598	0.0034	CcSEcCtD
Lapatinib—Headache—Diethylpropion—obesity	0.000595	0.00338	CcSEcCtD
Lapatinib—Malnutrition—Sibutramine—obesity	0.000591	0.00336	CcSEcCtD
Lapatinib—Back pain—Orlistat—obesity	0.000591	0.00336	CcSEcCtD
Lapatinib—Hot flush—Topiramate—obesity	0.000583	0.00332	CcSEcCtD
Lapatinib—Connective tissue disorder—Bupropion—obesity	0.000582	0.00331	CcSEcCtD
Lapatinib—CYP3A5—adipose tissue—obesity	0.000581	0.00534	CbGeAlD
Lapatinib—Menopausal symptoms—Topiramate—obesity	0.000578	0.00329	CcSEcCtD
Lapatinib—Vomiting—Cimetidine—obesity	0.000574	0.00327	CcSEcCtD
Lapatinib—CYP2C19—endocrine gland—obesity	0.000574	0.00527	CbGeAlD
Lapatinib—Back pain—Sibutramine—obesity	0.000572	0.00325	CcSEcCtD
Lapatinib—Rash—Cimetidine—obesity	0.00057	0.00324	CcSEcCtD
Lapatinib—Dermatitis—Cimetidine—obesity	0.000569	0.00324	CcSEcCtD
Lapatinib—Headache—Cimetidine—obesity	0.000566	0.00322	CcSEcCtD
Lapatinib—Nausea—Diethylpropion—obesity	0.000564	0.00321	CcSEcCtD
Lapatinib—Cardiac disorder—Bupropion—obesity	0.00055	0.00313	CcSEcCtD
Lapatinib—CYP3A5—digestive system—obesity	0.000547	0.00503	CbGeAlD
Lapatinib—Anaemia—Sibutramine—obesity	0.000547	0.00311	CcSEcCtD
Lapatinib—Pain in extremity—Topiramate—obesity	0.000545	0.0031	CcSEcCtD
Lapatinib—Palpitations—Orlistat—obesity	0.00054	0.00307	CcSEcCtD
Lapatinib—Angiopathy—Bupropion—obesity	0.000537	0.00306	CcSEcCtD
Lapatinib—Nausea—Cimetidine—obesity	0.000537	0.00305	CcSEcCtD
Lapatinib—Immune system disorder—Bupropion—obesity	0.000535	0.00304	CcSEcCtD
Lapatinib—Mediastinal disorder—Bupropion—obesity	0.000534	0.00304	CcSEcCtD
Lapatinib—Cough—Orlistat—obesity	0.000533	0.00303	CcSEcCtD
Lapatinib—Leukopenia—Sibutramine—obesity	0.000529	0.00301	CcSEcCtD
Lapatinib—Alopecia—Bupropion—obesity	0.000523	0.00298	CcSEcCtD
Lapatinib—Palpitations—Sibutramine—obesity	0.000523	0.00297	CcSEcCtD
Lapatinib—Myalgia—Orlistat—obesity	0.00052	0.00296	CcSEcCtD
Lapatinib—Mental disorder—Bupropion—obesity	0.000519	0.00295	CcSEcCtD
Lapatinib—CYP2C19—liver—obesity	0.000517	0.00475	CbGeAlD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000517	0.00294	CcSEcCtD
Lapatinib—Cough—Sibutramine—obesity	0.000516	0.00293	CcSEcCtD
Lapatinib—Malnutrition—Bupropion—obesity	0.000516	0.00293	CcSEcCtD
Lapatinib—Dehydration—Topiramate—obesity	0.000507	0.00288	CcSEcCtD
Lapatinib—Arthralgia—Sibutramine—obesity	0.000503	0.00286	CcSEcCtD
Lapatinib—Myalgia—Sibutramine—obesity	0.000503	0.00286	CcSEcCtD
Lapatinib—CYP2C8—endocrine gland—obesity	0.000501	0.0046	CbGeAlD
Lapatinib—Anaphylactic shock—Orlistat—obesity	0.000499	0.00284	CcSEcCtD
Lapatinib—Back pain—Bupropion—obesity	0.000499	0.00284	CcSEcCtD
Lapatinib—Infection—Orlistat—obesity	0.000495	0.00282	CcSEcCtD
Lapatinib—Nervous system disorder—Orlistat—obesity	0.000489	0.00278	CcSEcCtD
Lapatinib—Skin disorder—Orlistat—obesity	0.000484	0.00275	CcSEcCtD
Lapatinib—ABCB1—islet of Langerhans—obesity	0.000484	0.00445	CbGeAlD
Lapatinib—Anaphylactic shock—Sibutramine—obesity	0.000483	0.00274	CcSEcCtD
Lapatinib—Alanine aminotransferase increased—Topiramate—obesity	0.000481	0.00274	CcSEcCtD
Lapatinib—Infection—Sibutramine—obesity	0.000479	0.00273	CcSEcCtD
Lapatinib—Anaemia—Bupropion—obesity	0.000476	0.00271	CcSEcCtD
Lapatinib—Skin disorder—Sibutramine—obesity	0.000469	0.00267	CcSEcCtD
Lapatinib—Leukopenia—Bupropion—obesity	0.000461	0.00262	CcSEcCtD
Lapatinib—Anorexia—Sibutramine—obesity	0.00046	0.00262	CcSEcCtD
Lapatinib—ABCB1—respiratory system—obesity	0.000457	0.0042	CbGeAlD
Lapatinib—Palpitations—Bupropion—obesity	0.000456	0.00259	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Orlistat—obesity	0.000454	0.00258	CcSEcCtD
Lapatinib—CYP3A5—endocrine gland—obesity	0.000452	0.00415	CbGeAlD
Lapatinib—CYP2C8—liver—obesity	0.000451	0.00415	CbGeAlD
Lapatinib—Insomnia—Orlistat—obesity	0.000451	0.00257	CcSEcCtD
Lapatinib—Cough—Bupropion—obesity	0.00045	0.00256	CcSEcCtD
Lapatinib—Neutropenia—Topiramate—obesity	0.000441	0.00251	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Sibutramine—obesity	0.00044	0.0025	CcSEcCtD
Lapatinib—Dyspepsia—Orlistat—obesity	0.000439	0.0025	CcSEcCtD
Lapatinib—Myalgia—Bupropion—obesity	0.000439	0.0025	CcSEcCtD
Lapatinib—Arthralgia—Bupropion—obesity	0.000439	0.0025	CcSEcCtD
Lapatinib—Insomnia—Sibutramine—obesity	0.000437	0.00248	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000436	0.00248	CcSEcCtD
Lapatinib—Decreased appetite—Orlistat—obesity	0.000433	0.00247	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Orlistat—obesity	0.000431	0.00245	CcSEcCtD
Lapatinib—Dyspnoea—Sibutramine—obesity	0.00043	0.00245	CcSEcCtD
Lapatinib—Fatigue—Orlistat—obesity	0.00043	0.00245	CcSEcCtD
Lapatinib—Dyspepsia—Sibutramine—obesity	0.000425	0.00242	CcSEcCtD
Lapatinib—Pneumonia—Topiramate—obesity	0.000423	0.0024	CcSEcCtD
Lapatinib—Anaphylactic shock—Bupropion—obesity	0.000421	0.00239	CcSEcCtD
Lapatinib—Infestation NOS—Topiramate—obesity	0.00042	0.00239	CcSEcCtD
Lapatinib—Infestation—Topiramate—obesity	0.00042	0.00239	CcSEcCtD
Lapatinib—Decreased appetite—Sibutramine—obesity	0.00042	0.00239	CcSEcCtD
Lapatinib—Infection—Bupropion—obesity	0.000418	0.00238	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Sibutramine—obesity	0.000417	0.00237	CcSEcCtD
Lapatinib—Constipation—Sibutramine—obesity	0.000413	0.00235	CcSEcCtD
Lapatinib—Nervous system disorder—Bupropion—obesity	0.000413	0.00235	CcSEcCtD
Lapatinib—Neuropathy peripheral—Topiramate—obesity	0.000412	0.00234	CcSEcCtD
Lapatinib—CYP3A4—digestive system—obesity	0.00041	0.00377	CbGeAlD
Lapatinib—Stomatitis—Topiramate—obesity	0.00041	0.00233	CcSEcCtD
Lapatinib—Skin disorder—Bupropion—obesity	0.000409	0.00232	CcSEcCtD
Lapatinib—Gastrointestinal pain—Orlistat—obesity	0.000408	0.00232	CcSEcCtD
Lapatinib—CYP3A5—liver—obesity	0.000408	0.00375	CbGeAlD
Lapatinib—Anorexia—Bupropion—obesity	0.000401	0.00228	CcSEcCtD
Lapatinib—Epistaxis—Topiramate—obesity	0.000396	0.00225	CcSEcCtD
Lapatinib—Gastrointestinal pain—Sibutramine—obesity	0.000395	0.00224	CcSEcCtD
Lapatinib—Abdominal pain—Orlistat—obesity	0.000394	0.00224	CcSEcCtD
Lapatinib—ABCB1—adrenal cortex—obesity	0.000384	0.00353	CbGeAlD
Lapatinib—Musculoskeletal discomfort—Bupropion—obesity	0.000383	0.00218	CcSEcCtD
Lapatinib—Abdominal pain—Sibutramine—obesity	0.000382	0.00217	CcSEcCtD
Lapatinib—Insomnia—Bupropion—obesity	0.000381	0.00216	CcSEcCtD
Lapatinib—Dyspnoea—Bupropion—obesity	0.000375	0.00213	CcSEcCtD
Lapatinib—Connective tissue disorder—Topiramate—obesity	0.000371	0.00211	CcSEcCtD
Lapatinib—Dyspepsia—Bupropion—obesity	0.00037	0.00211	CcSEcCtD
Lapatinib—Hypersensitivity—Orlistat—obesity	0.000367	0.00209	CcSEcCtD
Lapatinib—Decreased appetite—Bupropion—obesity	0.000366	0.00208	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Bupropion—obesity	0.000363	0.00207	CcSEcCtD
Lapatinib—Fatigue—Bupropion—obesity	0.000363	0.00206	CcSEcCtD
Lapatinib—Constipation—Bupropion—obesity	0.00036	0.00205	CcSEcCtD
Lapatinib—Asthenia—Orlistat—obesity	0.000358	0.00203	CcSEcCtD
Lapatinib—Hypersensitivity—Sibutramine—obesity	0.000356	0.00202	CcSEcCtD
Lapatinib—Pruritus—Orlistat—obesity	0.000353	0.00201	CcSEcCtD
Lapatinib—Cardiac disorder—Topiramate—obesity	0.00035	0.00199	CcSEcCtD
Lapatinib—ABCB1—cardiovascular system—obesity	0.00035	0.00322	CbGeAlD
Lapatinib—Asthenia—Sibutramine—obesity	0.000346	0.00197	CcSEcCtD
Lapatinib—Gastrointestinal pain—Bupropion—obesity	0.000344	0.00196	CcSEcCtD
Lapatinib—Angiopathy—Topiramate—obesity	0.000342	0.00195	CcSEcCtD
Lapatinib—Pruritus—Sibutramine—obesity	0.000341	0.00194	CcSEcCtD
Lapatinib—Diarrhoea—Orlistat—obesity	0.000341	0.00194	CcSEcCtD
Lapatinib—Immune system disorder—Topiramate—obesity	0.000341	0.00194	CcSEcCtD
Lapatinib—Mediastinal disorder—Topiramate—obesity	0.00034	0.00193	CcSEcCtD
Lapatinib—CYP3A4—endocrine gland—obesity	0.000339	0.00312	CbGeAlD
Lapatinib—Alopecia—Topiramate—obesity	0.000333	0.0019	CcSEcCtD
Lapatinib—Abdominal pain—Bupropion—obesity	0.000333	0.00189	CcSEcCtD
Lapatinib—Mental disorder—Topiramate—obesity	0.000331	0.00188	CcSEcCtD
Lapatinib—Diarrhoea—Sibutramine—obesity	0.00033	0.00188	CcSEcCtD
Lapatinib—Malnutrition—Topiramate—obesity	0.000328	0.00187	CcSEcCtD
Lapatinib—Back pain—Topiramate—obesity	0.000318	0.00181	CcSEcCtD
Lapatinib—Vomiting—Orlistat—obesity	0.000317	0.0018	CcSEcCtD
Lapatinib—Rash—Orlistat—obesity	0.000314	0.00179	CcSEcCtD
Lapatinib—Dermatitis—Orlistat—obesity	0.000314	0.00179	CcSEcCtD
Lapatinib—Headache—Orlistat—obesity	0.000312	0.00178	CcSEcCtD
Lapatinib—Hypersensitivity—Bupropion—obesity	0.00031	0.00176	CcSEcCtD
Lapatinib—ABCB1—pituitary gland—obesity	0.00031	0.00285	CbGeAlD
Lapatinib—ABCB1—adipose tissue—obesity	0.000309	0.00284	CbGeAlD
Lapatinib—Vomiting—Sibutramine—obesity	0.000307	0.00175	CcSEcCtD
Lapatinib—CYP3A4—liver—obesity	0.000306	0.00281	CbGeAlD
Lapatinib—Rash—Sibutramine—obesity	0.000304	0.00173	CcSEcCtD
Lapatinib—Dermatitis—Sibutramine—obesity	0.000304	0.00173	CcSEcCtD
Lapatinib—Anaemia—Topiramate—obesity	0.000304	0.00173	CcSEcCtD
Lapatinib—Headache—Sibutramine—obesity	0.000302	0.00172	CcSEcCtD
Lapatinib—Asthenia—Bupropion—obesity	0.000302	0.00172	CcSEcCtD
Lapatinib—Pruritus—Bupropion—obesity	0.000298	0.00169	CcSEcCtD
Lapatinib—Nausea—Orlistat—obesity	0.000296	0.00168	CcSEcCtD
Lapatinib—Leukopenia—Topiramate—obesity	0.000294	0.00167	CcSEcCtD
Lapatinib—ABCB1—digestive system—obesity	0.000291	0.00267	CbGeAlD
Lapatinib—Palpitations—Topiramate—obesity	0.00029	0.00165	CcSEcCtD
Lapatinib—Diarrhoea—Bupropion—obesity	0.000288	0.00164	CcSEcCtD
Lapatinib—Nausea—Sibutramine—obesity	0.000287	0.00163	CcSEcCtD
Lapatinib—Cough—Topiramate—obesity	0.000287	0.00163	CcSEcCtD
Lapatinib—Myalgia—Topiramate—obesity	0.00028	0.00159	CcSEcCtD
Lapatinib—Arthralgia—Topiramate—obesity	0.00028	0.00159	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000278	0.00158	CcSEcCtD
Lapatinib—ABCB1—adrenal gland—obesity	0.000277	0.00254	CbGeAlD
Lapatinib—Vomiting—Bupropion—obesity	0.000268	0.00152	CcSEcCtD
Lapatinib—Infection—Topiramate—obesity	0.000266	0.00151	CcSEcCtD
Lapatinib—Rash—Bupropion—obesity	0.000265	0.00151	CcSEcCtD
Lapatinib—Dermatitis—Bupropion—obesity	0.000265	0.00151	CcSEcCtD
Lapatinib—Headache—Bupropion—obesity	0.000264	0.0015	CcSEcCtD
Lapatinib—Nervous system disorder—Topiramate—obesity	0.000263	0.0015	CcSEcCtD
Lapatinib—Skin disorder—Topiramate—obesity	0.00026	0.00148	CcSEcCtD
Lapatinib—Anorexia—Topiramate—obesity	0.000256	0.00145	CcSEcCtD
Lapatinib—Nausea—Bupropion—obesity	0.00025	0.00142	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Topiramate—obesity	0.000244	0.00139	CcSEcCtD
Lapatinib—Insomnia—Topiramate—obesity	0.000242	0.00138	CcSEcCtD
Lapatinib—ABCB1—endocrine gland—obesity	0.00024	0.00221	CbGeAlD
Lapatinib—Dyspnoea—Topiramate—obesity	0.000239	0.00136	CcSEcCtD
Lapatinib—Dyspepsia—Topiramate—obesity	0.000236	0.00134	CcSEcCtD
Lapatinib—Decreased appetite—Topiramate—obesity	0.000233	0.00133	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Topiramate—obesity	0.000231	0.00132	CcSEcCtD
Lapatinib—Fatigue—Topiramate—obesity	0.000231	0.00131	CcSEcCtD
Lapatinib—Constipation—Topiramate—obesity	0.000229	0.0013	CcSEcCtD
Lapatinib—Gastrointestinal pain—Topiramate—obesity	0.000219	0.00125	CcSEcCtD
Lapatinib—ABCB1—liver—obesity	0.000216	0.00199	CbGeAlD
Lapatinib—Abdominal pain—Topiramate—obesity	0.000212	0.00121	CcSEcCtD
Lapatinib—Hypersensitivity—Topiramate—obesity	0.000197	0.00112	CcSEcCtD
Lapatinib—Asthenia—Topiramate—obesity	0.000192	0.00109	CcSEcCtD
Lapatinib—Pruritus—Topiramate—obesity	0.00019	0.00108	CcSEcCtD
Lapatinib—Diarrhoea—Topiramate—obesity	0.000183	0.00104	CcSEcCtD
Lapatinib—Vomiting—Topiramate—obesity	0.00017	0.000969	CcSEcCtD
Lapatinib—Rash—Topiramate—obesity	0.000169	0.000961	CcSEcCtD
Lapatinib—Dermatitis—Topiramate—obesity	0.000169	0.00096	CcSEcCtD
Lapatinib—Headache—Topiramate—obesity	0.000168	0.000955	CcSEcCtD
Lapatinib—Nausea—Topiramate—obesity	0.000159	0.000906	CcSEcCtD
Lapatinib—EGFR—Signaling Pathways—APOE—obesity	4.92e-06	1.84e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—APOB—obesity	4.92e-06	1.84e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CYP2E1—obesity	4.88e-06	1.83e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—IL6—obesity	4.88e-06	1.83e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CAV1—obesity	4.88e-06	1.83e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—STK11—obesity	4.88e-06	1.83e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CYP19A1—obesity	4.88e-06	1.83e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—APOA1—obesity	4.87e-06	1.82e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—MTOR—obesity	4.86e-06	1.82e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—PIK3CB—obesity	4.86e-06	1.82e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL1B—obesity	4.86e-06	1.82e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ACP5—obesity	4.85e-06	1.82e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—NQO1—obesity	4.83e-06	1.81e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—PTGS2—obesity	4.82e-06	1.8e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CYP2E1—obesity	4.77e-06	1.79e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—obesity	4.73e-06	1.77e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—G6PD—obesity	4.72e-06	1.77e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—NQO1—obesity	4.71e-06	1.77e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—ESR1—obesity	4.7e-06	1.76e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—LPL—obesity	4.7e-06	1.76e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—obesity	4.69e-06	1.75e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—SREBF2—obesity	4.67e-06	1.75e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—HK1—obesity	4.67e-06	1.75e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—F2—obesity	4.64e-06	1.74e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PRKCB—obesity	4.64e-06	1.74e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GCG—obesity	4.63e-06	1.73e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—SLC2A4—obesity	4.63e-06	1.73e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—BAD—obesity	4.59e-06	1.72e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—GPX1—obesity	4.59e-06	1.72e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CYCS—obesity	4.57e-06	1.71e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—COMT—obesity	4.53e-06	1.7e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GCG—obesity	4.52e-06	1.69e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—SLC2A4—obesity	4.52e-06	1.69e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—LPA—obesity	4.51e-06	1.69e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—AKT1—obesity	4.5e-06	1.69e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GGT1—obesity	4.48e-06	1.68e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GOT1—obesity	4.48e-06	1.68e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GNB3—obesity	4.47e-06	1.67e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PPARGC1A—obesity	4.47e-06	1.67e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CD36—obesity	4.47e-06	1.67e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CYCS—obesity	4.46e-06	1.67e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—MAPK8—obesity	4.45e-06	1.67e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—HMOX1—obesity	4.45e-06	1.67e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PIK3CG—obesity	4.44e-06	1.66e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—NCOA1—obesity	4.42e-06	1.65e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—LPIN1—obesity	4.41e-06	1.65e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IRS1—obesity	4.39e-06	1.64e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GGT1—obesity	4.38e-06	1.64e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GOT1—obesity	4.38e-06	1.64e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—STK11—obesity	4.35e-06	1.63e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CYP19A1—obesity	4.35e-06	1.63e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GNAS—obesity	4.35e-06	1.63e-05	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—AKT1—obesity	4.32e-06	1.62e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—APOA5—obesity	4.32e-06	1.62e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—NCOA1—obesity	4.31e-06	1.61e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—PIK3CA—obesity	4.29e-06	1.61e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—APOB—obesity	4.26e-06	1.6e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—STK11—obesity	4.25e-06	1.59e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CYP19A1—obesity	4.25e-06	1.59e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—MTHFR—obesity	4.23e-06	1.58e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—POMC—obesity	4.23e-06	1.58e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—PIK3CA—obesity	4.23e-06	1.58e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—INS—obesity	4.21e-06	1.58e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PPARA—obesity	4.15e-06	1.55e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CCL2—obesity	4.14e-06	1.55e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CLOCK—obesity	4.12e-06	1.54e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—SLC22A1—obesity	4.12e-06	1.54e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—LPL—obesity	4.07e-06	1.52e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—STAT3—obesity	4.07e-06	1.52e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IGF1—obesity	4.07e-06	1.52e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—AKT2—obesity	4.07e-06	1.52e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—COMT—obesity	4.05e-06	1.52e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—AGT—obesity	4.02e-06	1.51e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—SULT2A1—obesity	4.02e-06	1.5e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GLP1R—obesity	4.02e-06	1.5e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GNB3—obesity	3.99e-06	1.49e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PPARGC1A—obesity	3.99e-06	1.49e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—HMOX1—obesity	3.97e-06	1.49e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GPX1—obesity	3.97e-06	1.49e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—DPYD—obesity	3.95e-06	1.48e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—COMT—obesity	3.95e-06	1.48e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—APOE—obesity	3.94e-06	1.48e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PIK3CD—obesity	3.91e-06	1.46e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CAV1—obesity	3.9e-06	1.46e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PPARGC1A—obesity	3.9e-06	1.46e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GNB3—obesity	3.9e-06	1.46e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—APOA1—obesity	3.89e-06	1.46e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GNAS—obesity	3.89e-06	1.46e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—HMOX1—obesity	3.88e-06	1.45e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CD36—obesity	3.87e-06	1.45e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—SERPINE1—obesity	3.86e-06	1.45e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—APOB—obesity	3.81e-06	1.42e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PRKAR2B—obesity	3.8e-06	1.42e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IL6—obesity	3.8e-06	1.42e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GNAS—obesity	3.79e-06	1.42e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—DCN—obesity	3.78e-06	1.41e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TYK2—obesity	3.76e-06	1.41e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—STAT3—obesity	3.76e-06	1.41e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IL6—obesity	3.75e-06	1.4e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—RHOA—obesity	3.73e-06	1.4e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—APOB—obesity	3.71e-06	1.39e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—NOS3—obesity	3.69e-06	1.38e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PIK3R1—obesity	3.69e-06	1.38e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CPT1A—obesity	3.67e-06	1.38e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—MTHFR—obesity	3.67e-06	1.37e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—LPL—obesity	3.63e-06	1.36e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—NAMPT—obesity	3.6e-06	1.35e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PPARA—obesity	3.6e-06	1.35e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—LIPC—obesity	3.58e-06	1.34e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GCK—obesity	3.58e-06	1.34e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—APOC3—obesity	3.56e-06	1.33e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PIK3CG—obesity	3.56e-06	1.33e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—LPL—obesity	3.55e-06	1.33e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GPX1—obesity	3.54e-06	1.33e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—PIK3CA—obesity	3.51e-06	1.32e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—AKT1—obesity	3.51e-06	1.31e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—MYC—obesity	3.49e-06	1.31e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—TGFB1—obesity	3.48e-06	1.3e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—AGT—obesity	3.48e-06	1.3e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GPX1—obesity	3.46e-06	1.3e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—AKT1—obesity	3.46e-06	1.29e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CETP—obesity	3.45e-06	1.29e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CD36—obesity	3.45e-06	1.29e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PPARG—obesity	3.43e-06	1.28e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—SDC1—obesity	3.42e-06	1.28e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—APOE—obesity	3.41e-06	1.28e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—MTOR—obesity	3.41e-06	1.28e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PIK3CB—obesity	3.41e-06	1.28e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—POMC—obesity	3.38e-06	1.27e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CAV1—obesity	3.38e-06	1.27e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—APOA1—obesity	3.37e-06	1.26e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CD36—obesity	3.37e-06	1.26e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—INS—obesity	3.37e-06	1.26e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—AKR1C3—obesity	3.36e-06	1.26e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—SCARB1—obesity	3.31e-06	1.24e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—MTHFR—obesity	3.27e-06	1.22e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—obesity	3.23e-06	1.21e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—SREBF1—obesity	3.21e-06	1.2e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—PIK3CA—obesity	3.21e-06	1.2e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PPARA—obesity	3.21e-06	1.2e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—MTHFR—obesity	3.19e-06	1.2e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PPARA—obesity	3.13e-06	1.17e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PIK3CD—obesity	3.13e-06	1.17e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GOT2—obesity	3.12e-06	1.17e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—IL6—obesity	3.11e-06	1.17e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—AGT—obesity	3.11e-06	1.16e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—ALB—obesity	3.09e-06	1.16e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PIK3CG—obesity	3.08e-06	1.15e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—FASN—obesity	3.06e-06	1.14e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—APOE—obesity	3.05e-06	1.14e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—BCHE—obesity	3.04e-06	1.14e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—AGT—obesity	3.03e-06	1.14e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CAV1—obesity	3.02e-06	1.13e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—APOA1—obesity	3.01e-06	1.13e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—APOE—obesity	2.97e-06	1.11e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PPARG—obesity	2.97e-06	1.11e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—PIK3CA—obesity	2.96e-06	1.11e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—MMP9—obesity	2.96e-06	1.11e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PIK3R1—obesity	2.95e-06	1.11e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—NOS3—obesity	2.95e-06	1.11e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CAV1—obesity	2.95e-06	1.1e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—APOA1—obesity	2.94e-06	1.1e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CYP2E1—obesity	2.94e-06	1.1e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—POMC—obesity	2.93e-06	1.1e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—INS—obesity	2.92e-06	1.09e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—NQO1—obesity	2.9e-06	1.09e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.88e-06	1.08e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—MAPK8—obesity	2.88e-06	1.08e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—AKT1—obesity	2.87e-06	1.07e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL6—obesity	2.84e-06	1.06e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—SLC2A4—obesity	2.78e-06	1.04e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GCG—obesity	2.78e-06	1.04e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PIK3CG—obesity	2.75e-06	1.03e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CYCS—obesity	2.75e-06	1.03e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PIK3CB—obesity	2.72e-06	1.02e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PIK3CD—obesity	2.71e-06	1.01e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PTGS2—obesity	2.7e-06	1.01e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GGT1—obesity	2.7e-06	1.01e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GOT1—obesity	2.7e-06	1.01e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PIK3CG—obesity	2.68e-06	1e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—ALB—obesity	2.67e-06	1e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—NCOA1—obesity	2.66e-06	9.95e-06	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PPARG—obesity	2.65e-06	9.93e-06	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—STAT3—obesity	2.63e-06	9.85e-06	CbGpPWpGaD
Lapatinib—EGFR—Disease—IL6—obesity	2.63e-06	9.83e-06	CbGpPWpGaD
Lapatinib—EGFR—Immune System—AKT1—obesity	2.62e-06	9.82e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—STK11—obesity	2.62e-06	9.8e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CYP19A1—obesity	2.62e-06	9.8e-06	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—POMC—obesity	2.62e-06	9.8e-06	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—INS—obesity	2.6e-06	9.74e-06	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PPARG—obesity	2.59e-06	9.7e-06	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PIK3R1—obesity	2.56e-06	9.57e-06	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—NOS3—obesity	2.56e-06	9.57e-06	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—POMC—obesity	2.55e-06	9.56e-06	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—INS—obesity	2.54e-06	9.51e-06	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—MYC—obesity	2.45e-06	9.16e-06	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TGFB1—obesity	2.44e-06	9.13e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—COMT—obesity	2.43e-06	9.11e-06	CbGpPWpGaD
Lapatinib—EGFR—Disease—AKT1—obesity	2.42e-06	9.07e-06	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PIK3CD—obesity	2.42e-06	9.05e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GNB3—obesity	2.4e-06	8.99e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PPARGC1A—obesity	2.4e-06	8.99e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—HMOX1—obesity	2.39e-06	8.95e-06	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ALB—obesity	2.39e-06	8.93e-06	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PIK3CB—obesity	2.36e-06	8.84e-06	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PIK3CD—obesity	2.36e-06	8.83e-06	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PTGS2—obesity	2.34e-06	8.75e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GNAS—obesity	2.34e-06	8.75e-06	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—ALB—obesity	2.33e-06	8.72e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—APOB—obesity	2.29e-06	8.57e-06	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PIK3R1—obesity	2.28e-06	8.54e-06	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—NOS3—obesity	2.28e-06	8.54e-06	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PIK3R1—obesity	2.23e-06	8.34e-06	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—NOS3—obesity	2.23e-06	8.34e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—LPL—obesity	2.18e-06	8.18e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GPX1—obesity	2.13e-06	7.98e-06	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PIK3CB—obesity	2.11e-06	7.89e-06	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PTGS2—obesity	2.09e-06	7.81e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CD36—obesity	2.08e-06	7.77e-06	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PIK3CA—obesity	2.08e-06	7.77e-06	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PIK3CB—obesity	2.06e-06	7.7e-06	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PTGS2—obesity	2.04e-06	7.63e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—MTHFR—obesity	1.97e-06	7.37e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PPARA—obesity	1.93e-06	7.23e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—AGT—obesity	1.87e-06	7e-06	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IL6—obesity	1.84e-06	6.88e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—APOE—obesity	1.83e-06	6.86e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CAV1—obesity	1.81e-06	6.79e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—APOA1—obesity	1.81e-06	6.78e-06	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—AKT1—obesity	1.7e-06	6.35e-06	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PIK3CA—obesity	1.66e-06	6.22e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PIK3CG—obesity	1.65e-06	6.19e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PPARG—obesity	1.6e-06	5.97e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—POMC—obesity	1.57e-06	5.89e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—INS—obesity	1.56e-06	5.86e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PIK3CD—obesity	1.45e-06	5.44e-06	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PIK3CA—obesity	1.44e-06	5.39e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ALB—obesity	1.43e-06	5.37e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—NOS3—obesity	1.37e-06	5.14e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PIK3R1—obesity	1.37e-06	5.14e-06	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—AKT1—obesity	1.36e-06	5.08e-06	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PIK3CA—obesity	1.28e-06	4.81e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PIK3CB—obesity	1.27e-06	4.74e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PTGS2—obesity	1.25e-06	4.7e-06	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PIK3CA—obesity	1.25e-06	4.69e-06	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—AKT1—obesity	1.18e-06	4.4e-06	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—AKT1—obesity	1.05e-06	3.93e-06	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—AKT1—obesity	1.02e-06	3.83e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PIK3CA—obesity	7.72e-07	2.89e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—AKT1—obesity	6.31e-07	2.36e-06	CbGpPWpGaD
